Tag: Invizius
Invizius raises further funds for the development of “breakthrough” dialysis treatment
Invizius has just announced that it has raised £950,000 in a funding round led by Mercia Ventures and supported by Calculus Capital, Syensqo, the...
Invizius’s dialysis product H-Guard completes first in-human clinical study
Invizius has recently announced via press release that eight patients have been successfully treated at the National Institute for Health and Care Research (NIHR)...
Invizius treats first patients in first-in-human phase 1 clinical study of...
Invizius has announced in a press release that the first two patients have been treated with its H-Guard priming solution in the company’s first-in-human...
Invizius appoints nephrologist Bernard Canaud to its clinical advisory board
Invizius, a biotechnology company developing treatments for patients on dialysis, announced today the appointment of Bernard Canaud to its clinical advisory board.
Canaud brings with...
Invizius receives MHRA approval to commence first-in-human clinical study of H-Guard...
Invizius has announced that it has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence its first-in-human clinical study...
Renal Interventions’ top 10 stories of June
June saw a variety of stories from across the renal world, including an in-depth interview with two of the authors of the new UK...
Invizius awarded grant to research peritoneal dialysis indication for H-Guard technology
Invizius recently announced that it has been awarded a second Biomedical Catalyst grant (Feasibility and Primer Award) by Innovate UK to research a new...